Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

526 recalls, newest first

Class I · High risk

365 SKINNY High Intensity Capsules

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.

Terminated Chemical / undeclared Je Dois Lavoir LLC D-0631-2022
Class I · High risk

Poseidon Platinum 3500 capsule

Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.

Terminated Chemical / undeclared Yamtun7 D-0654-2021
Class II · Moderate risk

Advance Hand Sanitizer

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv D-0647-2021
Class II · Moderate risk

ProtectoRx

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv NDC 75408-002-01 D-0646-2021
Class II · Moderate risk

DiBAR LABS Hand Sanitizer

CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv NDC 73009-001-16 D-0645-2021
Class I · High risk

DiBAR LABS Hand Sanitizer

Chemical Contamination: FDA analysis found 3 lots of DiBAR hand Sanitizer to be below the label claim for ethanol content and to contain methanol.

Terminated Chemical / undeclared Dibar Nutricional S De Rl De Cv NDC 73009-0001-08 D-0644-2021

Recalls by year